RecruitingPhase not listedNCT06566170
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Sponsor: Eli Lilly and Company
Huntsville, AL
2 recruiting alzheimer's disease studies with a site in Huntsville, AL.
All trials in Huntsville, AL · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Huntsville, AL
Sponsor: Celgene
Homewood, AL · Huntsville, AL · +58 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.